PCOS in Teens Demands Earlier Diagnosis to Prevent Lifelong Metabolic Harm

Polycystic ovary syndrome is one of the most prevalent endocrine disorders in women of reproductive age, yet diagnosing it during adolescence remains particularly difficult. Normal pubertal development — including irregular periods and mild androgen excess — closely resembles PCOS features, creating a genuine risk of both overdiagnosis and underdiagnosis during this developmental window.

This clinical review from the Developmental Endocrinology Unit at the University of São Paulo addresses how clinicians should approach PCOS diagnosis and management specifically in adolescent patients. It synthesizes current evidence and international guidelines to provide a practical framework for this challenging population.

The authors establish that a definitive PCOS diagnosis in adolescence requires clear, persistent evidence of both hyperandrogenism and menstrual irregularity. Teens presenting with only one criterion should be classified as at-risk and followed longitudinally rather than labeled prematurely. Alternative diagnoses that mimic PCOS — including thyroid disorders, hyperprolactinemia, and congenital adrenal hyperplasia — must be carefully excluded before any diagnosis is confirmed.

The review emphasizes that PCOS is not solely a reproductive condition. It carries significant metabolic risks including insulin resistance, dyslipidemia, and predisposition to type 2 diabetes, as well as elevated rates of anxiety and depression. This broader disease burden makes adolescence a critical intervention window. Management should begin with lifestyle modification — diet, physical activity, and weight management — as the foundational approach. Combined oral contraceptives are recommended as first-line pharmacotherapy for menstrual irregularity and hyperandrogenism, while metformin is advised for metabolic comorbidities, consistent with its role in adult PCOS management.

The clinical implication is clear: early, precise diagnosis and individualized treatment during adolescence could substantially reduce the long-term reproductive, metabolic, and psychosocial burden of PCOS across a woman's lifetime.